In 2018, CERN laid the foundations for a collaborative study to start in 2019, to tackle the design and the key components for a new generation of compact and cost-effective light-ion medical accelerators. The initiative, nicknamed “PIMMS2”, is following in the footsteps of the Proton Ion Medical Machine Study (PIMMS), hosted at CERN at the end of the 1990s and supported by MedAustron, Onkologie-2000 and the TERA Foundation. In order to gather initial input for this initiative, CERN, GSI Helmholtzzentrum für Schwerionenforschung (Centre for Heavy Ion Research), and the European Scientific Institute (ESI) jointly organised a workshop in June, where sixty experts from all over the world debated technical solutions for future ion therapy machines.

External contact person: 
Ready for licensing. Patented Technology. Granted in France, Europe, and USA. PCT. WO0144773.
WO0144773 - Granted in France, Europe, and USA. PCT.
Application Domain: 
Activity Domain: 
R&D Collaboration

You are here